SG

Stephen Goodall

Firebrick Pharma Limited | Founder, Chief Operating Officer, Executive Director
Dr Goodall has experience in intellectual property, pharmaceutical development, manufacturing, regulatory strategy and clinical development. Dr Goodall was Director of Pharmaceutical Development at Aptronics and Director of Development at AGEN Biomedical.

Company and Roles

Company
Title
Tenure
Since
FRE
FRE
Firebrick Pharma Limited
  • Founder
  • Chief Operating Officer
  • Executive Director
14yrs, 6mthApr 2012

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
FRE
FRE
Firebrick Pharma Limited
30/06/26N/A31,148,290N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
FRE
FRE
Firebrick Pharma Limited
20/05/26
Buy
110,000$0.046$5,060On-market trade
FRE
FRE
Firebrick Pharma Limited
10/10/24
Buy
181,818$0.055$10,000Participation in share purchase plan
FRE
FRE
Firebrick Pharma Limited
20/06/23
Transfer
30,326,472$0.155$4,700,603Off-market transfer
FRE
FRE
Firebrick Pharma Limited
20/06/23
Issued
530,000$0.150$79,500Placement
FRE
FRE
Firebrick Pharma Limited
20/06/23
Transfer
30,326,472$0.155$4,700,603Off-market transfer